2M6 Stock Overview
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 2M6 from our risk checks.
Medtronic plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$73.73 |
| 52 Week High | US$90.89 |
| 52 Week Low | US$68.50 |
| Beta | 0.81 |
| 1 Month Change | -13.51% |
| 3 Month Change | -10.59% |
| 1 Year Change | -2.99% |
| 3 Year Change | -27.60% |
| 5 Year Change | -22.29% |
| Change since IPO | 157.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2M6 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.7% | 3.3% | 5.6% |
| 1Y | -3.0% | -19.5% | 4.8% |
Return vs Industry: 2M6 exceeded the German Medical Equipment industry which returned -21.1% over the past year.
Return vs Market: 2M6 underperformed the German Market which returned 2% over the past year.
Price Volatility
| 2M6 volatility | |
|---|---|
| 2M6 Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 12.5% |
| 10% least volatile stocks in DE Market | 3.0% |
Stable Share Price: 2M6 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2M6's weekly volatility (4%) has been stable over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.
Medtronic plc Fundamentals Summary
| 2M6 fundamental statistics | |
|---|---|
| Market cap | €93.62b |
| Earnings (TTM) | €3.75b |
| Revenue (TTM) | €29.23b |
25.4x
P/E Ratio3.3x
P/S RatioIs 2M6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2M6 income statement (TTM) | |
|---|---|
| Revenue | US$33.20b |
| Cost of Revenue | US$11.42b |
| Gross Profit | US$21.78b |
| Other Expenses | US$17.52b |
| Earnings | US$4.26b |
Last Reported Earnings
Jan 24, 2025
Next Earnings Date
May 21, 2025
| Earnings per share (EPS) | 3.32 |
| Gross Margin | 65.59% |
| Net Profit Margin | 12.83% |
| Debt/Equity Ratio | 53.5% |
How did 2M6 perform over the long term?
See historical performance and comparisonDividends
3.3%
Current Dividend Yield85%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 18:10 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2025/01/24 |
| Annual Earnings | 2024/04/26 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medtronic plc is covered by 65 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kadambari Daptardar | Accountability Research Corporation |
| Harshit Gupta | Accountability Research Corporation |
| David Toung | Argus Research Company |